West Pharmaceutical Services logo

West Pharmaceutical Services

WST | NYSE
Chart Builder DCF Calculator
$417.80
+$1.38 (+0.33%)
At close: Nov 16, 2026, 4:00 PM ET
$417.80
$0.00 (0.00%)
After-hours: Nov 16, 2026, 5:54 PM ET
+0.33%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 16, 2026
66.5
Fundamentals Strong
Market Sentiment Neutral
Moat Wide
Sector Rank #79/1021 (Top 8%)

Key Statistics

Market Data

Market Cap $29.1B
1D Range
415.08 420.66
52W Range
230.95 420.66

Valuation (TTM)

PE 46.89
PB 9.81
EV/EBITDA 29.94

Valuation (NTM)

Forward PE 43.88
Forward PEG 1.38
Price Target $425.00
Loading financial charts...

Profile

West Pharmaceutical Services, Inc. (WST) specializes in the development, manufacturing, and global distribution of essential containment and delivery solutions for injectable pharmaceuticals and other...

Sector Healthcare
Employees 10,800
IPO Date Mar 17, 1980
Fiscal Year January - December

Latest News

West Pharmaceutical Services (WST) is a Great Momentum Stock: Should You Buy?

12 days ago · zacks.com

West Pharmaceutical Services (WST) is a Great Momentum Stock: Should You Buy?
West to Participate in Upcoming Investor Conference

13 days ago · prnewswire.com

West to Participate in Upcoming Investor Conference
What West Pharmaceutical Services (WST) Said on Its Q3 Earnings Call

17 days ago · marketbeat.com

What West Pharmaceutical Services (WST) Said on Its Q3 Earnings Call
West Pharmaceutical Services, Inc. (WST) Q3 2026 Earnings Call Transcript

18 days ago · seekingalpha.com

West Pharmaceutical Services, Inc. (WST) Q3 2026 Earnings Call Transcript
West Pharma Q3 Earnings Rise on HVP Strength, 2026 Outlook Raised

19 days ago · zacks.com

West Pharma Q3 Earnings Rise on HVP Strength, 2026 Outlook Raised
Compared to Estimates, West Pharmaceutical (WST) Q3 Earnings: A Look at Key Metrics

19 days ago · zacks.com

Compared to Estimates, West Pharmaceutical (WST) Q3 Earnings: A Look at Key Metrics
West Pharmaceutical Services (WST) Q3 Earnings and Revenues Top Estimates

19 days ago · zacks.com

West Pharmaceutical Services (WST) Q3 Earnings and Revenues Top Estimates
West Reports Third-Quarter 2026 Results

19 days ago · prnewswire.com

West Reports Third-Quarter 2026 Results
West Pharmaceutical (WST) Q3 Earnings Preview: What You Should Know Beyond the Headline Estimates

20 days ago · zacks.com

West Pharmaceutical (WST) Q3 Earnings Preview: What You Should Know Beyond the Headline Estimates
WST Q3 Earnings Preview: Will HVP Strength Offset Vantage Weakness?

21 days ago · zacks.com

WST Q3 Earnings Preview: Will HVP Strength Offset Vantage Weakness?

Earnings

Latest Earnings
Oct 29, 2026
EPS
$2.66
Beat +20.91%
REV
$874.5M
Beat +5.73%
Next Earnings
Feb 11, 2027
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

Analyst Summary

# of Analysts
8
Consensus
Buy
Price Target
$425.00
Upside
+1.72%
Buy (8)
Hold (0)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.